DDOST-CDG (CDG-Ir)
DDOST-CDG (CDG-Ir)
DDOST-CDG (CDG-Ir), also known as Congenital Disorder of Glycosylation type Ir, is a rare genetic disorder that affects the process of glycosylation, which is the attachment of sugars to proteins and lipids. This process is crucial for the proper function of many proteins and lipids in the body. DDOST-CDG is part of a larger group of disorders known as Congenital Disorders of Glycosylation (CDG).
Genetics
DDOST-CDG is caused by mutations in the DDOST gene, which encodes the enzyme dolichyl-diphosphooligosaccharide—protein glycosyltransferase subunit 1. This enzyme is essential for the initial steps of N-linked glycosylation, a type of glycosylation that occurs in the endoplasmic reticulum. Mutations in the DDOST gene lead to defective glycosylation, resulting in a wide range of clinical symptoms.
Clinical Features
The clinical presentation of DDOST-CDG can vary widely among affected individuals. Common symptoms include:
- Developmental delay
- Intellectual disability
- Hypotonia
- Seizures
- Coagulopathy
- Liver dysfunction
- Failure to thrive
Diagnosis
Diagnosis of DDOST-CDG typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Biochemical tests may show abnormal glycosylation patterns in serum glycoproteins. Genetic testing can confirm the diagnosis by identifying mutations in the DDOST gene.
Treatment
There is currently no cure for DDOST-CDG. Treatment is primarily supportive and symptomatic, focusing on managing the various symptoms and complications associated with the disorder. This may include physical therapy, occupational therapy, and medications to control seizures and other symptoms.
Prognosis
The prognosis for individuals with DDOST-CDG varies depending on the severity of the symptoms and the specific mutations involved. Early diagnosis and supportive care can improve the quality of life for affected individuals.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD